Abstract:Objective: To analyze the diagnostic and prognostic values of flow cytometry (FC) in diffuse large B cell lymphoma (DLBCL) with bone marrow involvement (BMI). Methods: The clinical data of 412 patients with newly diagnosed DLBCL, including 243 males and 169 females, aged 64 (28-92) years old, in the Department of Hematology at Peking University Third Hospital from December 2012 to June 2022 were retrospectively analyzed. All patients underwent bone marrow biopsy (BMB) and bone marrow FC. The patients with BMI by FC were further detected by fluorescence in situ hybridization (FISH) for gene analysis. The positive rates and consistency of BMI detected by BMB and FC were evaluated. According to the results of BMB and FC examinations, all patients were divided into four groups: the BMB+FC+group (115 cases), the BMB-FC+group (50 cases), the BMB+FC-group (8 cases, the results did not include in statistical analysis because of small sample size), and the BMB-FC-group (239 cases). The clinical features, treatment response rates, 5-year survival rates, and immunophenotype characteristics by FC in different groups were analyzed. Results: Among the 412 patients with DLBCL, the positivity rates of BMB and FC for BMI detection were 29.9% (123/412) and 40.0% (165/412), respectively. Good consistency between BMB and FC was found (Kappa=0.841, P=0.001). The numbers of extranodal involvement≥2, splenomegaly, huge mass, higher Ki-67 score, higher international prognostic index (IPI) score, thrombocytopenia, and elevated lactate dehydrogenase level were more prevalent in the BMB+FC+group than those in the BMB-FC+group and the BMB-FC-group (all P<0.05). The treatment response rate in BMB+FC+group was 63.5% (73/115), which was lower than those in BMB-FC+group (88.0%, 44/50, P=0.048) and BMB-FC-group (90.0%, 215/239, P=0.032), respectively. The 5-year overall survival rates in three groups were (53.6±9.7) %, (72.5±8.6) %, and (75.2±7.6) %, respectively, with a statistically significant difference (P=0.037). According to the FISH results of bone marrow, 102 cases were diagnosed as not otherwise specified (NOS), 48 cases were diagnosed as double hit lymphoma (DHL), and 15 cases were diagnosed as triple hit lymphoma (THL). Compared with NOS subtypes, the tumor cells in DHL or THL subtypes had higher proportion of increased side scatter (SSC), higher positive rates of CD10 expression, CD38 strong expression and CD56 expression, and lower proportion of surface immunoglobulin light chain restriction (all P<0.05). Conclusions: FC is well consistent with BMB in diagnosing DLBCL with BMI. Combined with FISH detection, FC can contribute to the auxiliary diagnosis and risk stratification for DHL and THL, and provide reference for the prognostic evaluation in DLBCL with BMI.

Clinical value of flow cytometry in assessing bone marrow involvement of non-Hodgkin's lymphoma

Effects of flow cytometry in bone marrow involvement of non-Hodgkin's lymphoma at initial diagnosis

[The Diagnostic Value of Flow Cytometry in Patients with Lymphoma Associated Hemophagocytic Syndrome].

[Application of Flow Cytometric Immunophenotypic Analysis in the Diagnosis of Malignant Lymphoma].

[Diagnostic and Prognostic Values of Flow Cytometry in Diffuse Large B-cell Lymphoma with Bone Marrow Involvement].

18F-FDG PET for evaluation on bone marrow involvement in patients with non-Hodgkin lymphoma

[Immunophenotype Analysis in 121 Patients with Lymphoproliferative Diseases by Flow Cytometry].

Clinical application value of bone marrow experimental diagnosis system on non-hodgkin's lymphoma

Flow Cytometric Analysis of Cerebrospinal Fluid in Adult Patients with Acute Lymphoblastic Leukemia During Follow-Up

[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]

[Application of Multiparameter Flow Cytometry in Diagnosis of Non-Hodgkin Lymphoma].

[Role of Flow Cytometry in the Diagnosis of Chronic Myeloid Leukemia].

Analysis of bone marrow cells by flow cytometry for diagnosis of lymphoma

Flow Cytometric Immunophenotyping of Fine-Needle Aspiration Specimens

Bone marrow involvement in follicular lymphoma: Comparison of histology and flow cytometry as staging procedures

Immunophenotype Character of Malignant Lymphoma with Bone Marrow Involvement

Diagnostic Value and Prognosis Significance of Cerebrospinal Fluid Examination by Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia

The application of flow cytometry in the diagnosis of tumor

Using flow cytometrv to detect minimal neuroblastoma cells in peripheral blood and bone marrow

Value of Multi-Parameter Flow Cytometry Immunophenotyping in T/NK-cell Neoplasms in Cytology Specimens: A Retrospective Study in Chinese Patients.

Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma